Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Spurious medicines worth Rs 52 lakh seized by authorities

      Spurious medicines worth Rs 52 lakh seized by authorities

      supriya kashyap kashyap21 Dec 2016 12:36 PM IST
      Ahmedabad : The Food and Drugs Control Administration (FDCA) here seized medicines, including antibiotics, worth over Rs 52 lakh, on suspicion of...
      Cipla gets USFDA nod for lipid regulating tablets

      Cipla gets USFDA nod for lipid regulating tablets

      supriya kashyap kashyap20 Dec 2016 11:18 AM IST
      New Delhi : Drug firm Cipla has received final approval from the US health regulator for lipid regulating Fenofibrate tablets.The company "has...
      Lupin launches voriconazole tablets

      Lupin launches voriconazole tablets

      supriya kashyap kashyap20 Dec 2016 11:18 AM IST
      New Delhi : Homegrown pharma major Lupin Ltd announced the launch of generic version of its voriconazole tablets and oral suspension used for...
      FDA grants accelerated approval to new treatment for advanced ovarian cancer

      FDA grants accelerated approval to new treatment for advanced ovarian cancer

      supriya kashyap kashyap20 Dec 2016 11:18 AM IST
      The U.S. Food and Drug Administration granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer....
      Novartis drug tops standard therapy in untreated lung cancer patients

      Novartis drug tops standard therapy in untreated lung cancer patients

      supriya kashyap kashyap17 Dec 2016 12:14 PM IST
      Novartis AG said its cancer drug, Zykadia, was twice as effective as standard chemotherapy in slowing the progression of a rare form of lung cancer in...
      GSK insider Waterhouse to head drugmaker HIV unit ViiV

      GSK insider Waterhouse to head drugmaker HIV unit ViiV

      supriya kashyap kashyap14 Dec 2016 12:27 PM IST
      GlaxoSmithKline said that Dominique Limet would step down at the end of March 2017 as head of the drugmaker's majority-owned HIV business ViiV...
      BD launches diagnostic instrument for rapid identification of bacteria and detection of antimicrobial resistance

      BD launches diagnostic instrument for rapid identification of bacteria and detection of antimicrobial resistance

      supriya kashyap kashyap14 Dec 2016 9:16 AM IST
      New Delhi : BD (Becton, Dickinson and Company), a global medical technology company, announced the launch of its next generation diagnostic...
      Aditya Birla Health Insurance looks at 8-10 percent market share

      Aditya Birla Health Insurance looks at 8-10 percent market share

      supriya kashyap kashyap11 Dec 2016 10:34 AM IST
      Kolkata : Aditya Birla Health Insurance, a joint venture between Aditya Birla Group and South Africa based MMI Holdings Ltd., is looking at a 8-10...
      FDA issues observations post Sun Pharma Halol plant inspection

      FDA issues observations post Sun Pharma Halol plant inspection

      supriya kashyap kashyap11 Dec 2016 10:33 AM IST
      New Delhi : Sun Pharmaceutical Industries said the United States health regulator has issued an observation letter after the completion of its Halol...
      Suven Life Sciences secures one product patent in India

      Suven Life Sciences secures one product patent in India

      supriya kashyap kashyap10 Dec 2016 10:32 AM IST
      Hyderabad : Suven Life Sciences Ltd announces that the grant of one product patent from India (2770440) corresponding to the New Chemical Entities...
      Boehringer gets US FDA nod for type 2 diabetes drug

      Boehringer gets US FDA nod for type 2 diabetes drug

      supriya kashyap kashyap9 Dec 2016 10:19 AM IST
      Mumbai : Pharma firm Boehringer Ingelheim said it has got approval from the US health regulator for a new indication for Jardiance (empagliflozin)...
      Divis Lab gets 5 observations from USFDA for Vizag plant

      Divis Lab gets 5 observations from USFDA for Vizag plant

      supriya kashyap kashyap9 Dec 2016 10:13 AM IST
      New Delhi : Drug firm Divis Laboratories said US health regulator has made five observations after inspection of its manufacturing plant at...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok